Quanterix Corp. agreed to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, combining two companies ...

Anavex Life Sciences' Blarcamesine trial raises concerns over approval. Learn why AVXL stock is undervalued, reflecting the ...

In October 2023, a group that included Elliott Investment Management, Patient Square Capital and Veritas Capital acquired ...

GLP-1 drugs, widely used for treating metabolic disorders, often face issues with long term tolerability, leading to side effects such as sarcopenia and bone density loss. These complications ...

It's one of many steps for the company as it builds the infrastructure for what "will change medicine everywhere in the world ...

From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...

Practice of medicine could fundamentally change with these types of therapies,” said CEO Jaideep Dudani, of T cell engagers ...